Metraipolis › archive › dc_1c889f6bb035
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41149461
- DOI
- 10.3390/curroncol32100541
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T17:32:46.079Z
- SHA-256 of the archived text
31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b- Stable URL of this page
https://metraipolis.com/documento/dc_1c889f6bb035
How to cite
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461 — Europe PMC (en), https://europepmc.org/article/MED/41149461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1c889f6bb035 (Metraipolis archive dc_1c889f6bb035, sha256 31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b)
BibTeX
@misc{dc1c889f6bb035,
title = {Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41149461},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1c889f6bb035; sha256 31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41149461. Agents can read the archived copy with the MCP tool read_document.